187 related articles for article (PubMed ID: 35831680)
1. Ischemic enteritis resulting from polycythemia vera.
Yagi S; Kioka K; Koizumi Y; Nakai T; Kawasaki Y; Tsutsumi M; Ishii N; Yamasaki T; Nebiki H; Maeda K
Clin J Gastroenterol; 2022 Oct; 15(5):907-912. PubMed ID: 35831680
[TBL] [Abstract][Full Text] [Related]
2. [Superior mesenteric and portal vein thrombosis in a polycythemia vera patient with JAK2 mutation].
Araki N; Takimoto R; Chiba H; Araki H; Sato T; Iyama S; Hirakawa M; Ono K; Kawano Y; Takada K; Miyanishi K; Kobune M; Matsunaga T; Kato J; Nakamura T; Niitsu Y
Rinsho Ketsueki; 2007 Jul; 48(7):554-8. PubMed ID: 17695304
[TBL] [Abstract][Full Text] [Related]
3. Ischemic Jejunal Stricture Secondary to Polycythemia Vera.
McFarquhar A; Bahdi F; Xu Y; Lu LB
Dig Dis Sci; 2023 Apr; 68(4):1077-1079. PubMed ID: 36609730
[No Abstract] [Full Text] [Related]
4. Cerebellar venous thrombosis mimicking a cerebellar tumor due to polycythemia vera: a case report.
Wen H; Jin D; Chen Y; Cui B; Xiao T
BMC Neurol; 2021 Jun; 21(1):225. PubMed ID: 34134639
[TBL] [Abstract][Full Text] [Related]
5. Small intestinal obstruction resulting from ischemic enteritis: a case report.
Takeuchi N; Naba K
Clin J Gastroenterol; 2013 Aug; 6(4):281-6. PubMed ID: 23990850
[TBL] [Abstract][Full Text] [Related]
6. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
[TBL] [Abstract][Full Text] [Related]
7. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
8. Ischemic stroke as an initial performance of polycythemia vera in young adults: A case report and literature review.
Hui S; Zhao J; Huo T; Dong L; Xie Y; Wang X; Zhang M
Medicine (Baltimore); 2024 Feb; 103(7):e36953. PubMed ID: 38363912
[TBL] [Abstract][Full Text] [Related]
9. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
10. Combined venous and arterial thrombosis revealing underlying myeloproliferative disorder in a young patient: a case report.
Benmalek R; Mechal H; Zahidi H; Mounaouir K; Arous S; Benouna MEG; Drighil A; Habbal R
J Med Case Rep; 2021 Feb; 15(1):76. PubMed ID: 33593422
[TBL] [Abstract][Full Text] [Related]
11. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
12. Polycythemia Vera Diagnosed after Esophageal Variceal Rupture.
Kono Y; Takaki A; Gobara H; Matsuoka K; Nishino M; Okada H; Yamamoto K
Intern Med; 2015; 54(18):2395-9. PubMed ID: 26370868
[TBL] [Abstract][Full Text] [Related]
13. Delayed intestinal stricture following non-resectional treatment for non-occlusive mesenteric ischemia associated with hepatic portal venous gas: a case report.
Maezawa S; Fujita M; Sato T; Kushimoto S
BMC Surg; 2015 Apr; 15():37. PubMed ID: 25885337
[TBL] [Abstract][Full Text] [Related]
14. [Polycythemia vera diagnosis during follow-up in a case of extrahepatic portal obstruction with portal biliopathy].
Ito R; Tanaka H; Iwane K; Takata R; Ikeda A; Dougaki M; Suga M; Hatanaka H; Waki S; Nakamura A
Nihon Shokakibyo Gakkai Zasshi; 2020; 117(5):421-429. PubMed ID: 32389914
[TBL] [Abstract][Full Text] [Related]
15. The first report of a JAK2 V617F-positive myeloproliferative neoplasm with initial manifestation as a rare pampiniform venous plexus thrombosis and review of the literature.
Jacobs J; Sharma D; Vnencak-Jones C
J Thromb Thrombolysis; 2022 Jan; 53(1):213-217. PubMed ID: 34240279
[TBL] [Abstract][Full Text] [Related]
16. A Case of Recurrent Ischemic Stroke Involving Subacute, Progressive Intracranial Cerebral Arterial Sclerosis Prior to Diagnosis with JAK2-mutated Polycythemia Vera.
Nezu T; Aoki S; Ochi K; Sugihara S; Takahashi T; Hosomi N; Maruyama H; Matsumoto M
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):e4-6. PubMed ID: 26432562
[TBL] [Abstract][Full Text] [Related]
17. [Role of the activating mutation Val617Phe of Janus kinase 2 gene in myeloproliferative diseases and significance of its detection].
Andrikovics H; Szilvási A; Meggyesi N; Király V; Halm G; Lueff S; Nahajevszky S; Mikala G; Sipos A; Lovas N; Csukly Z; Mátrai Z; Tamáska J; Tordai A; Masszi T
Orv Hetil; 2007 Feb; 148(5):203-10. PubMed ID: 17344140
[TBL] [Abstract][Full Text] [Related]
18. New and old prognostic factors in polycythemia vera.
Passamonti F
Curr Hematol Malig Rep; 2009 Jan; 4(1):19-24. PubMed ID: 20425434
[TBL] [Abstract][Full Text] [Related]
19. Subacute intestinal obstruction associated with a case of polycythemia vera--a rare combination.
Sinha RJ; Wahal A
J Pak Med Assoc; 2009 Aug; 59(8):562-3. PubMed ID: 19757706
[TBL] [Abstract][Full Text] [Related]
20. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
Zhan H; Spivak JL
Clin Adv Hematol Oncol; 2009 May; 7(5):334-42. PubMed ID: 19521323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
